CORRECTION article
Front. Oncol.
Sec. Gynecological Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1697346
This article is part of the Research TopicImmune Predictive and Prognostic Biomarkers in Immuno-Oncology: Refining the Immunological Landscape of CancerView all 41 articles
Correction: CS Ration is an immune – related prognostic biomarker for cervical cancer
Provisionally accepted
- 1Tianjin Medical University, Tianjin, China
- 2Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China
- 3Nankai University, Tianjin, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Frontiers' correction template for authors A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval. Instructions: ● Please read through all the templates before choosing ● Pick the most relevant text template(s) from the following page and delete all others. ● Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. ● Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary ● Submit to Frontiers following the instructions on this page. When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example: There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake. The original version of this article has been updated. In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).'' Correction: CS Ration is an immune – related prognostic biomarker for cervical cancer Correction on: Peiqin Shi, Wenwen Zhang, Qingqing Yao, Zhanna Yuan, Jiaqi Wang, Ziye Yang, Pengpeng Qu. CS Ration is an immune – related prognostic biomarker for cervical cancer. Frontiers in Oncology. 2025; 15: doi.org/10.3389/fonc.2025.1547529. Error in author list Changing author order The order of authors in the author list of the published paper was erroneously given as: [Peiqin Shi1, Wenwen Zhang2, Qingqing Yao3, Zhanna Yuan1,4, Jiaqi Wang1, Ziye Yang3, Pengpeng Qu1,3,5* * Corresponding author] The correct author list reads: [Peiqin Shi1#, Wenwen Zhang2#, Qingqing Yao3, Zhanna Yuan1,4, Jiaqi Wang1, Ziye Yang3, Pengpeng Qu1,3,5* # These authors have contributed equally to this work * Corresponding author] The original version of this article has been updated. Equal contribution statement Missing Author [Wenwen Zhang] was erroneously omitted as equal contributing author. The original version of this article has been updated. The original version of this article has been updated.
Keywords: same as original article, cervical cancer, CXCL9, SPP1, TCGA, GEO
Received: 02 Sep 2025; Accepted: 03 Sep 2025.
Copyright: © 2025 Shi, Zhang, Yao, Yuan, Wang, Yang and Qu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Pengpeng Qu, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.